1-12 of 12
Michael J Keating, M.D.
Close
Sort by
Journal Articles

STAT3 Is Constitutively Phosphorylated on Serine 727 Residues, Activates Transcription, and Plays a Major Role in the Pathogenesis of B-Cell Chronic Lymphocytic Leukemia.

Inbal Hazan-Halevy, PhD., David Harris, Zhiming Liu, Alessandra Ferrajoli, M.D., Michael J Keating, M.D., Zeev Estrov, M.D.
Journal: Blood
Blood (2008) 112 (11): 1058.
https://doi.org/10.1182/blood.V112.11.1058.1058
Published: 2008
Journal Articles

Importin-β1 and Nucleus Transporter Chromosome Region Maintenance 1 (CRM1) Constitute the Nucleocytoplasmic Transport System of STAT3 in Blood-Derived CLL Cells.

Inbal Hazan-Halevy, PhD., David Harris, Zhiming Liu, Alessandra Ferrajoli, MD., Michael J Keating, M.D., Zeev Estrov, MD
Journal: Blood
Blood (2008) 112 (11): 1059.
https://doi.org/10.1182/blood.V112.11.1059.1059
Published: 2008
Journal Articles

Treatment with Lenalidomide Has a Positive Immunomodulatory Effect in Patients with Chronic Lymphocytic Leukemia.

Hui Gao, PhD, Alessandra Ferrajoli, MD, Evan N Cohen, Bang-Ning Lee, PhD, Sanda Tin, M.D., Susan O’Brien, M.D., William G. Wierda, M.D., Ph.D, Zeev Estrov, M.D., Stefan Faderl, MD, Michael J Keating, M.D., James M. Reuben, PhD
Journal: Blood
Blood (2008) 112 (11): 2107.
https://doi.org/10.1182/blood.V112.11.2107.2107
Published: 2008
Journal Articles

Life after Fludarabine, Cyclophosphamide, & Rituximab (FCR) - the Clinical Outcome of Patients with Chronic Lymphocytic Leukemia Who Receive Salvage Treatment after Frontline FCR.

Constantine S. Tam, William G. Wierda, M.D., Ph.D, Susan O’Brien, Susan Lerner, Issa F Khouri, Hagop M. Kantarjian, Michael J Keating, M.D.
Journal: Blood
Blood (2008) 112 (11): 2090.
https://doi.org/10.1182/blood.V112.11.2090.2090
Published: 2008
Journal Articles

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Analysis of 2083 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Susan O’Brien, M.D., Peter McLaughlin, M.D., Sijin Wen, M.S., William Wierda, M.D., Ph.D., Hagop M. Kantarjian, M.D., John Manning, M.D., Susan Lerner, M.S., Mark Hess, B.B.A., Emil J. Freireich, M.D., Michael J. Keating, M.D.
Journal: Blood
Blood (2006) 108 (11): 2790.
https://doi.org/10.1182/blood.V108.11.2790.2790
Published: 2006
Journal Articles

Prognostic Significance of β-2 Microglobulin Levels in Acute Myeloid Leukemia: Analysis of 1293 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Hagop M. Kantarjian, M.D., Michael J. Keating, M.D., Susan O’Brien, M.D., Sijin Wen, M.S., Jorge Cortes, M.D., Francis Giles, M.D., Charles Asa Koller, M.D., Guillermo Garcia-Manero, M.D., Sherry Pierce, B.S.N., Mark Brandt, Emil J. Freireich, M.D., Elihu H. Estey, M.D.
Journal: Blood
Blood (2006) 108 (11): 802.
https://doi.org/10.1182/blood.V108.11.802.802
Published: 2006
Journal Articles

Study of VH3-21 in a Large Cohort of Chronic Lymphocytic Leukemia Patients Reveals Evidence for Antigen Selection and Confirms Its Predictive Value for Early Disease Progression.

Emanuela M. Ghia, PhD, Laura Z. Rassenti, Ph.D., George F. Widhopf, Ph.D., Donna S. Neuberg, Ph.D., Michael J. Keating, M.D., William G. Wierda, M.D., Ph.D., John G. Gribben, M.D., Jennifer R. Brown, M.D., Ph.D., Ian W. Flinn, M.D., Ph.D., Kanti R. Rai, M.D., John C. Byrd, M.D., Neil E. Kay, M.D., Andrew W. Greaves, B.S., Thomas J. Kipps, M.D.,Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2774.
https://doi.org/10.1182/blood.V108.11.2774.2774
Published: 2006
Journal Articles

A Prognostic Score for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Analysis of 2189 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Peter McLaughlin, M.D., Susan O’Brien, M.D., Sijin Wen, M.S., William G. Wierda, M.D., Ph.D., John Manning, M.D., Susan Lerner, M.S., Mark A. Hess, Hagop Kantarjian, M.D., Emil J. Freireich, M.D., Michael J. Keating, M.D.
Journal: Blood
Blood (2006) 108 (11): 2783.
https://doi.org/10.1182/blood.V108.11.2783.2783
Published: 2006
Journal Articles

Combination of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Richter’s Syndrome and Fludarabine-Refractory Chronic Lymphocytic Leukemia.

Apostolia-Maria Tsimberidou, MD, PhD, William G. Wierda, M.D., Ph.D., Susan O’Brien, M.D., William W. Plunkett, M.D., Thomas J. Kipps, M.D., Jennifer R. Brown, M.D., Ph.D, Susan Lerner, M.S., Hagop Kantarjian, M.D., Michael J. Keating, M.D.
Journal: Blood
Blood (2006) 108 (11): 2825.
https://doi.org/10.1182/blood.V108.11.2825.2825
Published: 2006
Journal Articles

Genomic Aberrations in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma by Absolute Lymphocyte Count: Analysis of 1694 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Peter McLaughlin, M.D., Susan O’Brien, M.D., Sijin Wen, M.S., William G. Wierda, M.D., Ph.D., John T. Manning, M.D., Lynne V. Abruzzo, M.D., Ph.D., Susan Lerner, M.S., Mark A. Hess, B.B.A., Hagop M. Kantarjian, M.D., Emil J. Freireich, M.D., Michael J. Keating, M.D.
Journal: Blood
Blood (2006) 108 (11): 4958.
https://doi.org/10.1182/blood.V108.11.4958.4958
Published: 2006
Journal Articles

Granulocytic Sarcoma (GS) Is Associated with Event-Free Survival Superior to That of Acute Myeloid Leukemia (AML).

Apostolia-Maria Tsimberidou, MD, PhD, Michael J. Keating, M.D., Hagop M. Kantarjian, M.D., Susan O’Brien, M.D., Jorge Cortes, M.D., Charles Koller, M.D., BA, Francis Giles, M.D., Sherry Pierce, BSN, BA, Mark Brandt, Miloslav Beran, M.D., Ph.D., Elihu Estey, M.D.
Journal: Blood
Blood (2006) 108 (11): 2008.
https://doi.org/10.1182/blood.V108.11.2008.2008
Published: 2006
Journal Articles

Development of Forodesine Hydrochloride (FH), an Inhibitor of Purine Nucleoside Phosphorylase, for Patients with Chronic Lymphocytic Leukemia (CLL).

Kumudha Balakrishnan, PhD, Farhad Ravandi, M.D, Michael J. Keating, M.D, Varsha Gandhi, Ph.D
Journal: Blood
Blood (2005) 106 (11): 2119.
https://doi.org/10.1182/blood.V106.11.2119.2119
Published: 2005